QVAR Inhaler Antitrust Settlement
Filed against QVAR Inhaler · Deadline: July 31, 2026
People who used QVAR Inhaler often qualify for 101 more open settlements
- Unknown · John Deere $99 Million Equipment Repair Claims Settlement
- Unknown · NAR $120M Homebuyer Antitrust Class Action Settlement
- Unknown · New $117 Million Pork Price-Fixing Class Action Settlement
Free to download. Answer a few questions about the brands you use to see every match.
About This Settlement
You may be eligible if you purchased, paid for, or reimbursed for QVAR or QVAR Redihaler in an eligible state between January 1, 2015 and July 31, 2025.
Filing Has Closed
The deadline to file a claim was July 31, 2026. The administrator is no longer accepting claims, and there is nothing to submit here. If you filed before the deadline, any payment comes from the administrator directly.
Check the official settlement site for distribution updates →Frequently Asked Questions
How much can I get from the QVAR Inhaler settlement?
The estimated payout is $50, ranging from $10 to $300. Actual amounts depend on the number of valid claims filed.
What is the deadline to file a claim?
The claim deadline was July 31, 2026 and it has passed. The administrator is no longer accepting claims for this settlement.
Do I need proof to file a claim?
Yes, you may need to provide supporting documentation such as receipts or account records.
Can I still file a claim?
No. Filing for this settlement has closed and late claims are not accepted. Browse the settlements still open below — most people qualify for more than one.
Who is eligible for this settlement?
This settlement is available to eligible consumers in the United States. Check the official settlement notice for detailed eligibility criteria.
More QVAR Inhaler Settlements
Other Antitrust Settlements
See every settlement you qualify for
Tell SettleScout which brands you use and it matches you with open settlements, estimates your payouts, and reminds you before every deadline.
Free to download. Premium plans available.